Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail
Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
The proposed study is a Type 1 hybrid effectiveness-implementation trial. Individuals with
opioid use disorder in county jails throughout the state of Maryland will be randomly
assigned within gender within jail to one of two groups: Arm 1. XR-B (n=120). XR-B in jail
followed by 6 monthly injections post-release at a community treatment program. Arm 2. XR-NTX
(n=120). One injection of XR-NTX in jail, followed by 6 monthly injections post-release at a
community treatment program.